BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3068033)

  • 1. The influence of ascorbic acid on the free-radical metabolism of xenobiotics: the example of diaziquone.
    Gutierrez PL
    Drug Metab Rev; 1988; 19(3-4):319-43. PubMed ID: 3068033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of diaziquone free radicals on the in vitro activity of diaziquone.
    Nguyen B; Biswal S; Gutierrez PL
    Xenobiotica; 1988 May; 18(5):593-602. PubMed ID: 2840783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular pharmacology in murine and human leukemic cell lines of diaziquone (NSC 182986).
    Egorin MJ; Fox BM; Spiegel JF; Gutierrez PL; Friedman RD; Bachur NR
    Cancer Res; 1985 Mar; 45(3):992-9. PubMed ID: 3971389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free radicals in quinone-containing antitumor agents. Electrochemical reduction of diaziquone (2,5-diaziridine-3,6-bis(carboethoxyamino)-1,4 -benzoquinone) and two analogues.
    Gutierrez PL; Fox BM; Mossoba MM; Bachur NR
    Mol Pharmacol; 1984 Nov; 26(3):582-6. PubMed ID: 6092903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular activation of diaziquone [2,5-diaziridinyl-3,6-bis (carboethoxyamino)-1,4-benzoquinone] to its free radical species.
    Gutierrez PL; Egorin MJ; Fox BM; Friedman R; Bachur NR
    Biochem Pharmacol; 1985 May; 34(9):1449-55. PubMed ID: 3994758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical activation of AZQ [3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone] to its free radical species.
    Gutierrez PL; Friedman RD; Bachur NR
    Cancer Treat Rep; 1982 Feb; 66(2):339-42. PubMed ID: 6275990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ascorbic acid on biologically obtained diaziquone free radicals.
    Gutierrez PL; Egorin MJ; Davis TA; Bachur NR
    Biochem Pharmacol; 1985 Jul; 34(13):2394-7. PubMed ID: 2990485
    [No Abstract]   [Full Text] [Related]  

  • 8. Reductive activation of diaziquone and possible involvement of free radicals and the hydroquinone dianion.
    Gutierrez PL; Biswal S; Nardino R; Biswal N
    Cancer Res; 1986 Nov; 46(11):5779-85. PubMed ID: 3019536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro multidrug resistance of P388 murine leukemia selected for resistance to diaziquone.
    Gutierrez PL; Wilder PJ; Biswal N
    Cancer Commun; 1989; 1(3):181-90. PubMed ID: 2576972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reductive metabolism of diaziquone (AZQ) in the S9 fraction of MCF-7 cells: free radical formation and NAD(P)H: quinone-acceptor oxidoreductase (DT-diaphorase) activity.
    Fisher GR; Gutierrez PL
    Free Radic Biol Med; 1991; 10(6):359-70. PubMed ID: 1654286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The murine disposition and pharmacokinetics of the antineoplastic agent, diaziquone (NSC 182986).
    Spiegel JF; Egorin MJ; Collins JM; Lerner BD; Bachur NR
    Drug Metab Dispos; 1983; 11(1):41-6. PubMed ID: 6132794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism(s) of bioreductive activation. The example of diaziquone (AZQ).
    Gutierrez PL
    Free Radic Biol Med; 1989; 6(4):405-45. PubMed ID: 2651223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of DNA strand breakage and interstrand cross-linking by diaziridinylbenzoquinone (diaziquone) in isolated nuclei from human cells.
    Szmigiero L; Kohn KW
    Cancer Res; 1984 Oct; 44(10):4453-7. PubMed ID: 6467205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free radical formation and DNA strand breakage during metabolism of diaziquone by NAD(P)H quinone-acceptor oxidoreductase (DT-diaphorase) and NADPH cytochrome c reductase.
    Fisher GR; Gutierrez PL
    Free Radic Biol Med; 1991; 11(6):597-607. PubMed ID: 1663902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of diaziquone by NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase): role in diaziquone-induced DNA damage and cytotoxicity in human colon carcinoma cells.
    Siegel D; Gibson NW; Preusch PC; Ross D
    Cancer Res; 1990 Nov; 50(22):7293-300. PubMed ID: 2121335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemical reduction of diaziquone: products and free radical intermediates.
    Gutierrez PL; Balachandran Nayar MS; Nardino R; Callery PS
    Chem Biol Interact; 1987; 64(1-2):23-37. PubMed ID: 2826025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electron spin resonance of electrochemically generated free radicals from diaziquone and its derivatives.
    Gutierrez PL; Fox BM; Mossoba MM; Egorin MJ; Nakazawa H; Bachur NR
    Biophys Chem; 1985 Jun; 22(1-2):115-23. PubMed ID: 2992620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diaziquone-glutathione conjugates: characterization and mechanisms of formation.
    Gutierrez PL; Siva S
    Chem Res Toxicol; 1995; 8(3):455-64. PubMed ID: 7578933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of p53 by the concerted actions of aziridine and quinone moieties of diaziquone.
    Ngo EO; Nutter LM; Sura T; Gutierrez PL
    Chem Res Toxicol; 1998 Apr; 11(4):360-8. PubMed ID: 9548807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of NAD(P)H:quinone oxidoreductase in quinone-mediated p21 induction in human colon carcinoma cells.
    Qiu XB; Cadenas E
    Arch Biochem Biophys; 1997 Oct; 346(2):241-51. PubMed ID: 9343371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.